US Corporate Distress Financial Stress SEC Filings — March 25, 2026

25-03-2026

Sandisk Technologies, Inc., a wholly-owned subsidiary of Sandisk Corporation, entered into a Private Placement Subscription Agreement with Nanya Technology Corporation on March 25, 2026, to purchase approximately 139 million shares of Nanya common stock for $1.0B, representing 3.9% of Nanya’s outstanding common stock on a fully diluted basis at a 15% discount to the 30-day average trading price. Concurrently, the companies entered a multi-year strategic supply arrangement for Nanya to supply DRAM products to support Sandisk's long-term sourcing strategy. The transaction shares are subject to a statutory 3-year lock-up period under Taiwanese law.

• ·Transaction conducted pursuant to Article 43-6 of the Taiwan Securities and Exchange Act, subject to post-closing filings with Taiwan Stock Exchange and other regulators.
• ·Shares subject to statutory 3-year lock-up from delivery, with limited transfer exceptions under Taiwanese law.

25-03-2026

Merck announced a definitive agreement to acquire Terns Pharmaceuticals for $53.00 per share in cash, valuing the equity at approximately $6.7B ($5.7B net of cash), a 31% premium to the 60-day VWAP and 42% to the 90-day VWAP as of March 24, 2026. The deal expands Merck's hematology pipeline with TERN-701, an investigational oral allosteric BCR::ABL1 TKI in Phase 1/2 for CML, expected to close in Q2 2026 subject to antitrust approval and tender offer conditions, resulting in a $5.8B charge ($2.35/share) to Merck's Q2 and FY2026 results. While promising early clinical data shows encouraging responses and low adverse events, the transaction carries risks including regulatory delays and shareholder litigation.

• ·Dose escalation of CARDINAL trial completed January 2025 with no dose-limiting toxicities up to 500mg QD.
• ·Dose expansion initiated April 2025 with 320mg or 500mg QD cohorts (up to 40 patients each).
• ·Additional CARDINAL cohort added January 2026 for BCR::ABL1 resistance mutations (e.g., T315I) in ~20 patients.
• ·FDA granted Orphan Drug Designation for TERN-701 in CML in March 2024.
• ·Merck investor call held March 25, 2026 at 8 a.m. EDT.
• ·Transaction via tender offer; merger agreement to be filed with SEC.

25-03-2026

Cipher Digital Inc., a subsidiary of Cipher Mining Inc., entered into a senior secured revolving credit agreement dated March 23, 2026, with a lender syndicate led by Morgan Stanley Senior Funding, Inc. as Administrative Agent and Collateral Agent, and joint arrangers including Banco Santander, Goldman Sachs Lending Partners LLC, JPMorgan Chase Bank, N.A., Sumitomo Mitsui Banking Corporation, and Wells Fargo Securities, LLC. Proceeds are for working capital and general corporate purposes, with interest margins starting at Term SOFR +1.750% / ABR +0.750% (adjustable down to +1.250% / +0.250% based on Consolidated Total Debt to Market Capitalization Ratio <0.30x) and a 0.50% commitment fee; no facility size or drawdowns specified.

• ·Pricing grid based on Consolidated Total Debt to Market Capitalization Ratio: Level 1 (<0.30:1) 1.250%/0.250%; Level 2 (0.30-0.60:1) 1.500%/0.500%; Level 3 (>0.60:1) 1.750%/0.750% for Term SOFR/ABR.
• ·Initial pricing effective until Compliance Certificate for fiscal quarter ending September 30, 2026.
• ·Alternate Base Rate defined as highest of 1.00%, Prime Rate, Federal Funds Effective Rate + 0.50%, or Adjusted Term SOFR (1-month) + 1.00%.

25-03-2026

Longeveron Inc. received a Nasdaq notice on March 24, 2026, granting an additional 180 days until September 21, 2026, to regain compliance with the $1.00 minimum bid price requirement after missing the initial 180-day deadline of March 23, 2026, stemming from an original deficiency notice on September 22, 2025. The company's Class A common stock listing on The Nasdaq Capital Market remains effective with no immediate impact. Management plans to monitor stock price and may pursue a reverse stock split, though success is not assured.

• ·Initial Nasdaq deficiency notice issued September 22, 2025, due to closing bid price below $1.00 for 30 consecutive business days.
• ·Compliance requires $1.00 closing bid price for at least 10 consecutive business days.
• ·Company classified as emerging growth company.

25-03-2026

Comstock Inc. appointed three new independent directors—Donald A. Colvin (effective immediately, to join Audit and Finance Committee), Robert M. Spence (effective immediately, Chair of Audit and Finance and Compensation Committees), and Steven Y. Pei (effective April 15, 2026)—to strengthen governance amid growth in solar recycling and critical metals recovery. Walter 'Del' Marting Jr. will serve as Non-Executive Chairman through the 2027 Annual Meeting, after which Kristin Slanina assumes the role, while William J. Nance and Marting committed not to stand for re-election. These changes followed constructive dialogue with significant shareholders MAK Capital Fund LP and Gratia Capital LLC.

• ·Colvin's prior CFO roles at Caesars Entertainment, ON Semiconductor, Atmel, and others; serves on boards of Maxeon Solar Technologies, Viavi Solutions, Agilysys.
• ·Pei founded Gratia Capital in 2012; prior roles at Canyon Capital, Bain Capital, McKinsey.
• ·Spence currently Director at Ecobat (battery recycling); prior General Counsel at Skyline Champion and Neenah Enterprises.
• ·Company uses www.comstock.inc, X.com, LinkedIn, YouTube for Regulation FD disclosures.

25-03-2026

Synergy CHC Corp., along with guarantors Synergy CHC Inc. and HAND MD CORP., entered into a Second Amendment to its Term Loan Credit Agreement on March 24, 2026, with ACP Agency, LLC serving as administrative and collateral agent. The amendment requires the issuance of a Common Stock Purchase Warrant to the lender, execution of an Amended and Restated Fee Letter, and payment of a $55,000 KTBS Installment Fee to KTBS Law LLP. No specific changes to loan terms or financial metrics are detailed in the filing.

• ·Original Term Loan Credit Agreement dated May 30, 2025
• ·First Amendment dated June 24, 2025
• ·SEC 8-K filing date: March 25, 2026
• ·Items reported: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 9.01 (Financial Statements and Exhibits)

25-03-2026

SOBR Safe, Inc. received a Nasdaq deficiency letter on March 19, 2026, notifying failure to satisfy the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2) for 30 consecutive business days. Prior reverse stock splits (1-for-110 on October 2, 2024, and 1-for-10 on April 4, 2025, cumulative 1-for-1100) render the company ineligible for the standard 180-day compliance period. The company intends to appeal to a hearings panel with a compliance plan, staying delisting pending hearing, though success is not assured.

• ·Company's common stock continues to trade on Nasdaq under ticker 'SOBR' with no immediate delisting effect.
• ·Notification does not impact business operations or SEC reporting requirements.
• ·Cumulative reverse stock split ratio over last two years: 1-for-1100, exceeding 1-for-250 threshold for standard compliance period.

25-03-2026

Prairie Operating Co. entered into an Amendment to its Securities Purchase Agreement dated March 25, 2026, with the Buyers of its previously issued 148,250 shares of Series F Preferred Stock (stated value $1,000 per share, totaling $148.25M). The amendment changes the Anniversary Warrant Issuance Date to April 7, 2026, updates related references, and obligates the Company to pay an aggregate $3M to the Buyers on April 6, 2026, unless waived by the Buyers.

• ·Warrants to purchase Common Stock equal to 125% of the Stated Value of held Series F Preferred Stock divided by the average of the 10 daily VWAPs prior to original issuance date, issuable April 7, 2026 subject to conditions.
• ·Original Purchase Agreement dated March 26, 2025.

25-03-2026

Cheetah Net Supply Chain Service Inc. entered into a Stock Purchase Agreement on March 25, 2026, to sell all 10,000 shares of its wholly-owned subsidiary, Edward Transit Express Group, Inc., to Bing Shao for an aggregate purchase price of $20,000 in cash. The transaction aims to streamline operations, reduce the adverse impact of the subsidiary's ocean package transportation and freight forwarding business on the company's results, and enable focus on new strategic acquisition opportunities. Closing is expected within 20 calendar days of execution.

• ·Includes execution of a Support and Restrictive Covenant Agreement with mutual non-disparagement obligations and a general release of claims by the Seller against the Subsidiary.
• ·Shares to be sold free and clear of any liens other than transfer restrictions imposed by applicable securities laws.

25-03-2026

On March 20, 2026, Waste Management, Inc. entered into Amendment No. 2 to its Seventh Amended and Restated Revolving Credit Agreement originally dated May 8, 2024. The amendment modifies the definitions of EBIT and EBITDA to include add-backs for equity-based compensation and interest accretion as non-cash items in the leverage ratio financial covenant calculation under Section 9. This change aims to enhance comparability with industry peers' covenant treatments.

• ·Amendment filed as Exhibit 10.1
• ·Credit Agreement among Company, Waste Management of Canada Corporation and WM Quebec Inc. as Borrowers, with Bank of America, N.A. as Administrative Agent

25-03-2026

The Trade Desk, Inc. (Nasdaq: TTD) announced the appointment of Drew Vollero, Reddit's CFO, to its Board of Directors on March 25, 2026. Vollero brings over three decades of financial and operational experience, including prior CFO roles at Allied Universal and Snapchat, where he guided IPOs and scaling efforts. CEO Jeff Green praised Vollero's expertise in helping high-growth tech companies navigate complex markets and deliver long-term value.

• ·Reddit IPO guided by Vollero in March 2024.
• ·Vollero holds B.A. in mathematics and economics from Yale University (magna cum laude) and M.S. in management from Oxford University.
• ·The Trade Desk headquartered in Ventura, CA, with offices in North America, Europe, and Asia Pacific.

25-03-2026

Albemarle Corporation entered into the Third Amendment to its 2022 Credit Agreement on March 19, 2026, extending the maturity date to the later of October 28, 2028 or one year thereafter under certain conditions. The amendment also deletes a 0.10% adjustment for SOFR-based loan interest calculations and reduces the number of allowable maturity date extension requests from two to one. No financial amounts or performance metrics were disclosed.

• ·Previous amendments to the 2022 Credit Agreement occurred on February 9, 2024 and October 31, 2024.
• ·The Third Amendment is filed as Exhibit 10.1.

25-03-2026

EnerSys announced plans to close its lead-acid battery manufacturing facility in Tijuana, Mexico, expecting to incur a pre-tax charge of approximately $37 million, including $14 million in non-cash charges and $23 million in cash costs primarily for severance, retention, environmental, and decommissioning expenses. The restructuring, aimed at optimizing costs, mitigating tariff risks, and strengthening domestic supply chains, will shift production to the Springfield, Missouri facility and result in an estimated annual pre-tax benefit of $20 million starting in fiscal year 2028, but involves a reduction of approximately 474 employees. The plan is expected to be substantially complete by December 2027.

• ·Majority of charges expected by second half of fiscal year 2027
• ·Plans to sell land, buildings, and possibly plant and equipment
• ·Production majority to be moved to existing facility in Springfield, Missouri

25-03-2026

New Fortress Energy Inc. filed a Certificate of Elimination to remove all references to its 4.8% Series A Convertible Preferred Stock (96,746 authorized shares, filed March 20, 2024) and 4.8% Series B Convertible Preferred Stock (96,746 authorized shares, filed October 1, 2024) from its Certificate of Incorporation, as none are outstanding and none will be issued. The Board adopted resolutions on March 11, 2026, to effect this change under Section 151(g) of the Delaware General Corporation Law. The certificate was executed by CFO Christopher S. Guinta on March 25, 2026.

• ·Series A Certificate of Designations filed with Delaware Secretary of State on March 20, 2024.
• ·Series B Certificate of Designations filed with Delaware Secretary of State on October 1, 2024.
• ·Board resolutions adopted on March 11, 2026.

25-03-2026

Mainz Biomed N.V. received a Nasdaq notice on March 20, 2026, stating that its ordinary shares (QUCY) failed to meet the $1.00 minimum bid price requirement over 30 consecutive business days from February 5 to March 19, 2026, violating Nasdaq Listing Rule 5550(a)(2). The company has a 180-day compliance period until September 16, 2026, to achieve a $1.00 closing bid price for at least 10 consecutive business days, with potential for an additional 180 days if eligible, but faces delisting risk otherwise. There is no immediate impact on current listing and trading on Nasdaq Capital Market.

• ·Trading symbol: QUCY
• ·Nasdaq Listing Rule 5550(a)(2) violated; compliance under Rule 5810(c)(3)(A)
• ·Possible reverse stock split to cure deficiency
• ·Right to appeal Nasdaq delisting determination if issued
• ·Company is an emerging growth company

25-03-2026

Twin Vee PowerCats Co. (NASDAQ: VEEE) announced the pricing of a best-efforts at-the-market offering of 6,491,900 shares of common stock at $0.384 per share, expecting gross proceeds of approximately $2.5 million before fees and expenses. The net proceeds will be used primarily for working capital and general corporate purposes, with the offering expected to close on March 24, 2026, subject to customary conditions. ThinkEquity is serving as the sole placement agent.

• ·Offering conducted under Nasdaq at-the-market rules pursuant to shelf registration statement on Form S-3 (File No. 333-293911), filed February 27, 2026, and effective March 5, 2026.
• ·Company manufactures boats under Twin Vee and Bahama Boat Works brands in Fort Pierce, Florida.
• ·Press release dated March 23, 2026; 8-K filed March 25, 2026.

25-03-2026

CIMG Inc. reported Q1 FY2026 revenue of $15,768,796, up dramatically from $22,853 in the prior-year period, driven by expansion into medicine-food homology products and new computing power solutions with clients including China Merchants Bank. The company held 730 Bitcoins valued at $63,978,821 as of December 31, 2025, though subject to significant market volatility, and book value per share stood at $3.6. While advancing strategic transformation with new subsidiaries and acquisitions, CIMG faces Nasdaq delisting risks and is appealing a compliance decision.

• ·Established wholly-owned subsidiaries in Shenzhen and Foshan, China.
• ·Acquired Braincon Limited (HK) and its subsidiary Beijing Xin Miao Shi Dai Technology Development Co., Ltd.
• ·Computing power product series launched in September 2025.
• ·Filed appeal against Nasdaq delisting decision.

25-03-2026

Apogee Therapeutics, Inc. entered into an underwriting agreement on March 24, 2026, to issue and sell 5,000,000 shares of common stock at $70.00 per share. The underwriters exercised in full their option to purchase an additional 750,000 shares. Net proceeds from the offering, including the option exercise, are expected to be approximately $377.4 million, with closing anticipated on March 26, 2026.

• ·Underwriting agreement includes indemnification of underwriters against certain liabilities under the Securities Act of 1933.
• ·Shelf registration statement (File No. 333-281503) effective August 12, 2024; final prospectus supplement filed March 25, 2026.
• ·Option exercisable for 30 days from March 24, 2026, and exercised in full on March 25, 2026.

25-03-2026

On March 19, 2026, SelectQuote, Inc. received a notice from the NYSE stating non-compliance with Section 802.01C due to the average closing price of its common stock falling below $1.00 over a consecutive 30 trading-day period. The Company plans to notify the NYSE of its intent to cure the deficiency within a six-month period, during which its stock will continue trading on the NYSE subject to other listing standards. No financial metrics were reported, highlighting ongoing stock price weakness as a key risk.

• ·Compliance rule: Section 802.01C of the NYSE Listed Company Manual
• ·Cure period: six months from March 19, 2026
• ·Stock symbol: SLQT (Common Stock, $0.01 par value)
• ·Press release issued: March 25, 2026 (Exhibit 99.1)

25-03-2026

Senior Credit Investments, LLC entered into the First Amendment to its Revolving Credit Agreement, originally dated March 21, 2025, with Sumitomo Mitsui Trust Bank, Limited, New York Branch as Administrative Agent, Arranger, and Lender, effective as of March 20, 2026. The amendment extends the Stated Maturity Date and makes other unspecified changes to the agreement. The filing confirms no Default or Event of Default exists post-amendment, with representations and warranties remaining true.

• ·Amendment requires execution by Borrower, Administrative Agent, and all Lenders; receipt of Amended and Restated Fee Letter; and payment of fees and expenses.
• ·Credit Agreement amended via Annex A (deletions and additions indicated by strikethrough and double-underline).
• ·Governed by New York law.

25-03-2026

BioLargo, Inc. entered into a purchase agreement with Clearthink Capital Partners, LLC on March 20, 2026, committing to purchase up to $10.0 million of the company's common stock over a 36-month period at the company's discretion, subject to conditions including SEC registration effectiveness. As consideration, BioLargo issued 500,000 commitment shares to Clearthink with no cash proceeds. Proceeds from any future sales are expected for working capital and general corporate purposes, with no restrictions on future financings and an ownership limit of 9.99% for Clearthink.

• ·Regular purchases limited to the lesser of $500,000 or 300% of the average daily traded value over the prior 8 trading days, with a minimum of $25,000 per notice.
• ·At least five business days must elapse between purchase notices unless mutually agreed otherwise.
• ·Purchase price based on average of the two lowest daily closing prices during the 8 trading days preceding the notice.
• ·Clearthink prohibited from short sales or hedging establishing a net short position during the term.
• ·Company can terminate agreement anytime with one business day's notice at no cost.

25-03-2026

Ballston Spa Bancorp, Inc. (OTCQX: BSPA), holding company for Ballston Spa National Bank, completed a $26 million subordinated notes private placement to qualified institutional buyers and accredited investors to support its proposed merger with NBC Bancorp, Inc. (OTCID: NCXS), holding company for The National Bank of Coxsackie. The notes mature April 1, 2036, bear a fixed 7.375% interest rate through April 1, 2031 then floating at 90-day SOFR plus 378 basis points, are redeemable on or after April 1, 2031 or upon certain regulatory events, and qualify as Tier 2 capital. Net proceeds will fund the bank merger and general corporate purposes for the combined entity.

• ·Filing date: March 25, 2026
• ·Notes not registered under Securities Act of 1933; private placement only
• ·Griffin Financial Group LLC and Brean Capital LLC as placement agents; Luse Gorman, PC as legal counsel to BSNB; Stevens & Lee as legal counsel to placement agents

25-03-2026

Nuburu, Inc. and Nuburu Defense, LLC entered into a letter of intent on March 19, 2026, with shareholders of Tekne S.p.A. to acquire a 70% equity interest through conversion of EUR 16.692 million in total convertible receivables (including a prior EUR 13 million from January 2026), a EUR 13 million capital increase for 25%, and EUR 6 million cash for an additional 10%, building on a prior 2.9% stake. The transaction is subject to Italian Golden Power authorization and includes plans for restructuring, potential industrial complex acquisition, drone manufacturing development, and a spin-off of non-core assets. While outlining strategic expansion, it carries risks such as regulatory approval delays and failure to realize anticipated benefits.

• ·Transaction effective subject to Presidenza del Consiglio dei Ministri GP Authorization
• ·Potential purchase or financial lease of industrial complex in Ortona (CH), Contrada Villa Caldari
• ·Share Transfer and Shareholder Convertible Loan Agreement effective January 13, 2026

25-03-2026

Immix Biopharma, Inc. entered into Amendment No. 1 on March 25, 2026, to its At The Market Offering Agreement originally dated June 3, 2025, with Citizens JMP Securities, LLC, enabling the sale of up to $100,000,000 in common stock shares through the sales agent. The agent receives a 3.0% commission on gross sales proceeds and reimbursement of certain expenses up to $50,000. No shares have been sold yet under this amended agreement, which operates under an effective Form S-3 registration statement.

• ·Original Sales Agreement dated June 3, 2025
• ·Form S-3 registration statement (File No. 333-292665) filed January 9, 2026, effective January 22, 2026
• ·Prospectus supplement filed March 25, 2026
• ·Legal opinion on validity of shares issued by Blank Rome LLP (Exhibit 5.1)

25-03-2026

P3 Health Partners, LLC entered into a Statement of Work (SOW) effective March 19, 2026, with a large unnamed nonprofit health insurance provider in Nebraska, incorporating a Master Services Agreement (MSA), to provide clinical, operational, and data-driven support under its Care Enablement Model to primary care providers in the Client’s Medicare Advantage network. The Client will pay management services fees for performance years 2026 and 2027, shifting to a global risk agreement from 2028 onward, with the MSA initial term through December 31, 2030, and automatic renewals unless terminated with specified notice. Termination provisions include options for material breach, performance failures in 2026, key personnel departures, or non-bid for Medicare Advantage plans, potentially triggering a breakup fee capped at an agreed amount.

• ·MSA auto-renews for one-year terms post-2030 unless 180 days' notice given.
• ·Client can terminate on 90 days' notice if 2026 performance metrics unmet or key persons depart.
• ·SOW terminates automatically if Client skips CMS bid for 2027-2028 Medicare Advantage plan, with breakup fee based on costs not exceeding agreed cap.
• ·Company to provide termination assistance services for transition.

25-03-2026

CDT Equity Inc. amended its Second Amended and Restated Certificate of Incorporation to authorize 250,000,000 shares of Common Stock and 1,000,000 shares of Preferred Stock, each with a par value of $0.0001 per share. Effective March 26, 2026 at 5:00pm Eastern Time, the company will implement a one-for-twenty-five reverse stock split of its Common Stock, with no fractional shares issued and cash payments made in lieu thereof based on the Nasdaq closing price from the prior trading day. The amendment was executed on March 24, 2026, by CEO Andrew Regan.

• ·Reverse stock split ratio: 1-for-25, with no reduction in authorized Common Stock shares.
• ·Cash in lieu of fractional shares calculated as fraction multiplied by proportionately adjusted closing price on Nasdaq from last trading day before March 26, 2026, 5:00pm ET.

25-03-2026

CarParts.com, Inc. (PRTS) expanded its partnership with A-Premium to launch approximately 30,000 SKUs of JC Whitney branded mechanical auto parts, with an initial 6,000 SKUs expected in early Q2 2026, building on a prior $35.7M investment from September 2025 now generating ~$35M annualized revenue. The initiative is funded by an $8M private placement of 10M common shares at $0.80 per share. This follows four consecutive quarters of operational improvements, including a $7.7M YoY decline in Q4 operating expenses.

• ·CarParts.com operates a nationwide distribution network providing 2-day delivery to ~95% of continental US.
• ·Partnership leverages A-Premium's strengths in product development, sourcing, inventory management, content, and fulfillment.
• ·Inventory investment expected to be accretive to earnings at attractive contribution margins.

25-03-2026

Next Technology Holding Inc. (NASDAQ: NXTT) announced a registered direct offering with twenty investors for 71,381,818 shares of common stock at $1.10 per share and pre-funded warrants to purchase 71,381,818 shares at $1.099 per warrant, expecting aggregate gross proceeds of approximately $157 million. The transaction is expected to close on or about March 26, 2026, subject to customary conditions. No comparative financial metrics or declines were reported in the announcement.

• ·Filing date: March 25, 2026
• ·Expected closing date: on or about March 26, 2026
• ·Shelf registration statement effective: November 20, 2025 (File No. 333-290266)
• ·Company incorporated: March 28, 2019 in Wyoming

25-03-2026

On March 17, 2026, OneMeta Inc. entered into a First Amendment to its October 31, 2025 Note and Warrant Purchase Agreement, consolidating $2M in Existing Notes with $0.2M Additional Notes issued on February 11, 2026, into a single $2.2M principal amount with maturity on the earlier of March 26, 2026 or an Event of Default. Noteholders can elect repayment in cash, common stock at the conversion price, or new preferred stock at the lowest price paid to unaffiliated third parties. The amendment includes a most-favored-nation clause allowing holders to adopt more favorable terms from any future convertible instruments issued by the Company.

• ·Original Note and Warrant Purchase Agreement dated October 31, 2025
• ·Amended Notes include right to amend for more favorable terms from Future Instruments, exercisable within 30 days of notice

25-03-2026

La Rosa Holdings Corp. amended its November 2025 Securities Purchase Agreement (SPA) with ATW AI Infrastructure III LLC and ATW AI Infrastructure IIIB LLC, originally for up to $250M in senior secured convertible notes, to specify use of equity offering proceeds: initially 20% to deferred advisor fees ($751,220.76 total), 40% to acquire Note Purchased Crypto as treasury assets, and 40% for general purposes including AI data center development, shifting to 50/50 thereafter plus $77,000 additional fees by Dec 31, 2026. The Token Right was also amended, increasing the holder's share of tokens from Other Financing to 56.25% from 25%. Company to reimburse up to $65,000 in legal expenses from equity proceeds.

• ·At Additional Closings under SPA, 90% of net proceeds for Note Purchased Crypto treasury assets.
• ·Equity proceeds post-deferred fees payment: 50% to Note Purchased Crypto, 50% general purposes including AI infrastructure.
• ·SPA dated November 12, 2025; amendments effective March 24, 2026.

25-03-2026

The Andersons, Inc. entered into an Amended and Restated Credit Agreement dated March 20, 2026, with a syndicate of lenders including U.S. Bank National Association as Administrative Agent, Bank of America, N.A., Truist Bank, Wells Fargo Bank, and others as co-syndication agents. The agreement provides for Five-Year Revolving Loans, Five-Year Term Loans, and Eight-Year Term Loans, with associated CUSIPs (Deal: 03416EAF8, Revolving: 03416EAG6, Five-Year Term: 03416EAL5, Eight-Year Term: 03416EAK7). No specific commitment amounts, financial metrics, or performance changes are disclosed in the filing.

• ·CUSIPs: Deal (03416EAF8), Five-Year Revolving Loan (03416EAG6), Five-Year Term Loan (03416EAL5), Eight-Year Term Loan (03416EAK7)
• ·Filing date: March 25, 2026; Agreement effective date: March 20, 2026
• ·Lenders include U.S. Bank National Association (Administrative Agent, LC Issuer, Swing Line Lender), and joint lead arrangers/bookrunners such as BOFA Securities, Inc., Truist Securities, Inc.

25-03-2026

Ford Credit Auto Owner Trust 2026-A issued asset-backed securities (Notes) as described in the Prospectus dated March 17, 2026, filed by Ford Credit Auto Receivables Two LLC (Depositor). The Depositor and/or the Trust entered into key Transaction Documents dated March 1, 2026, including the Indenture with The Bank of New York Mellon, Second Amended and Restated Trust Agreement with U.S. Bank Trust National Association, Receivables Purchase Agreement and Sale and Servicing Agreement with Ford Motor Credit Company LLC (Sponsor), and others. No financial performance metrics or comparisons are provided in the filing.

• ·Date of earliest event reported: March 24, 2026
• ·Prospectus filed pursuant to Rule 424(b)(2)
• ·Exhibits include: Exhibit 4.1 (Indenture), Exhibit 10.1 (Trust Agreement), Exhibit 10.2 (Receivables Purchase Agreement), Exhibit 10.3 (Sale and Servicing Agreement), Exhibit 10.4 (Administration Agreement), Exhibit 10.5 (Account Control Agreement), Exhibit 10.6 (Asset Representations Review Agreement)

25-03-2026

CAVA Group, Inc. entered into Amendment No. 3 to its existing Credit Agreement dated March 11, 2022, effective March 20, 2026, to increase Revolving Credit Commitments, extend the Initial Revolving Credit Maturity Date, and make other amendments. The amendment involves Departing Lenders Capital One, N.A. and Royal Bank of Canada, whose outstanding loans were repaid and commitments terminated, alongside the addition of New Lenders and CARDCO CCCIX, INC. as a new Subsidiary Guarantor. Other changes include the release of the Verona Mortgage and an extension of a post-closing obligation deadline to March 3, 2026.

• ·Amendment replaces Schedule 1.01(a) (Commitment Schedule), Schedule 5.15 (Post-Closing Obligations), and Exhibit D; deletes Exhibits A-1, B, H, N, and Q.
• ·Original Credit Agreement dated March 11, 2022.
• ·SEC filing date: March 25, 2026.

25-03-2026

Mobile Infrastructure Corporation entered into the Third Amendment to its Credit Agreement dated March 24, 2026, extending the Stated Maturity Date to June 30, 2026, with lenders Harvest Small Cap Partners, L.P. (Onshore Lender and Administrative Agent) and Harvest Small Cap Partners Master, Ltd. (Offshore Lender). The amendment confirms no Default or Event of Default exists and ratifies all prior loan documents without other changes. This provides additional runway for debt repayment amid ongoing amendments from the original September 11, 2024 agreement.

• ·Original Credit Agreement dated September 11, 2024; First Amendment dated September 5, 2025; Second Amendment dated December 23, 2025
• ·Effectiveness subject to execution by Borrower, Administrative Agent, and Lenders (Third Amendment Effective Date)
• ·Governed by laws of the State of New York

25-03-2026

Volato Group, Inc. terminated its ATM Sales Agreement with Virtu Americas LLC, which had allowed for the offer and sale of up to $9,300,000 in Class A Common Stock shares. Prior to termination on March 22, 2026, the company had only sold shares worth $477,090.84 under the agreement, representing a small fraction of the potential raise. No further sales will occur under the now-terminated agreement originally entered on December 5, 2025.

• ·Agreement terminated pursuant to Section 13(b), with Notice of Termination delivered on March 19, 2026.
• ·Securities: Class A Common Stock (SOAR, NYSE American LLC); Warrants exercisable at $287.50 per share (SOARW, OTC Markets Group, Inc.)
• ·Company is an emerging growth company.